EarningsQ3 2024 Earnings Report

Vertex Pharmaceuticals (1VRTX) Q3 2024 Earnings Report

4 Followers

IT:1VRTX Q3 2024 EPS Results

Actual EPS€3.91

Consensus EPS€3.64

Beat/MissBeat by +€0.27

One Year Ago EPS€3.64

Actual Revenue€2.48B

Expected Revenue€2.40B

Beat/MissBeat by +€79.89M

YoY Revenue Growth+11.86%

QuarterQ3 2024

Date11/04/2024

TimeAfter Close

Conference CallMonday, November 4, 2024

IT:1VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 2, 2026, based on past reporting schedules.

IT:1VRTX Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 02, 2026	2026 (Q3)	4.25 / -	4.283	―
Aug 03, 2026	2026 (Q2)	4.23 / 4.22	4.033	4.65% (+0.19)
May 04, 2026	2026 (Q1)	3.79 / 3.99	3.622	10.10% (+0.37)
Feb 12, 2026	2025 (Q4)	4.56 / 4.49	3.551	26.38% (+0.94)
Nov 03, 2025	2025 (Q3)	4.08 / 4.28	3.908	9.59% (+0.37)
Aug 06, 2025	2025 (Q2)	3.83 / 4.03	-11.447	135.23% (+15.48)
May 05, 2025	2025 (Q1)	3.85 / 3.62	4.247	-14.71% (-0.62)
Feb 10, 2025	2024 (Q4)	3.58 / 3.55	3.747	-5.24% (-0.20)
Nov 04, 2024	2024 (Q3)	3.64 / 3.91	3.64	7.35% (+0.27)
Aug 01, 2024	2024 (Q2)	-10.37 / -11.45	3.471	-429.82% (-14.92)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed